On ECHEMI
Home > Drugs > Hainan Lingkang Pharmaceutical Co., Ltd.

Hainan Lingkang Pharmaceutical Co., Ltd.

  • Founded in:

    2013-04-22
  • Country:

    China China
  • Address:

    No. 16, Yaogu Erheng Road, Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province
  • Tax NO.:

    91460000062331438Q
  • Registered Funds:

    200 million yuan
  • Website:

  • Email:

Related Drugs
Cefuroxime Sodium for Injection
The main ingredient of this product is cefuroxime sodium.
Name Description Content CAS NO. Registered Holders
Ceftizoxime sodium

This product belongs to the third generation of cephalosporin, with broad-spectrum antibacterial effect, and is stable to the broad-spectrum beta-lactamase produced by various Gram-positive and Gram-negative bacteria. It has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. Its effect on Staphylococcus aureus and Staphylococcus epidermidis is worse than that of the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, and Clostridium difficile is resistant to this product. The mechanism of action is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, with broad-spectrum antibacterial effect, and is stable to the broad-spectrum beta-lactamase produced by various Gram-positive and Gram-negative bacteria. It has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. Its effect on Staphylococcus aureus and Staphylococcus epidermidis is worse than that of the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, and Clostridium difficile is resistant to this product. The mechanism of action is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

68401-82-1 21
Cefuroxime Sodium for Injection
The main ingredient of this product is cefuroxime sodium.
Name Description Content CAS NO. Registered Holders
Ceftizoxime sodium

This product belongs to the third generation of cephalosporin, with a broad-spectrum antibacterial effect, and is stable against broad-spectrum beta-lactamases (including penicillinase and cephalosporinase) produced by various Gram-positive and Gram-negative bacteria. This product has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. This product has a poorer effect on Staphylococcus aureus and Staphylococcus epidermidis than the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, while Clostridium difficile is resistant to this product. The mechanism of action of this product is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, with a broad-spectrum antibacterial effect, and is stable against broad-spectrum beta-lactamases (including penicillinase and cephalosporinase) produced by various Gram-positive and Gram-negative bacteria. This product has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. This product has a poorer effect on Staphylococcus aureus and Staphylococcus epidermidis than the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, while Clostridium difficile is resistant to this product. The mechanism of action of this product is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

68401-82-1 21
Cefuroxime Sodium for Injection
The main ingredient of this product is cefuroxime sodium.
Name Description Content CAS NO. Registered Holders
Ceftizoxime sodium

This product belongs to the third generation of cephalosporin, with a broad-spectrum antibacterial effect. It is stable against broad-spectrum beta-lactamases (including penicillinase and cephalosporinase) produced by various Gram-positive and Gram-negative bacteria. It has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. Its effect on Staphylococcus aureus and Staphylococcus epidermidis is worse than that of the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, while Clostridium difficile is resistant to this product. The mechanism of action is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, with a broad-spectrum antibacterial effect. It is stable against broad-spectrum beta-lactamases (including penicillinase and cephalosporinase) produced by various Gram-positive and Gram-negative bacteria. It has a strong antibacterial effect on Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Pseudomonas and Acinetobacter species such as Pseudomonas aeruginosa are less sensitive to this product. Ceftizoxime has a good antibacterial effect on Haemophilus influenzae and Neisseria gonorrhoeae. Its effect on Staphylococcus aureus and Staphylococcus epidermidis is worse than that of the first and second generation cephalosporins. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to this product, and various streptococci are highly sensitive to this product. Anaerobic bacteria such as Peptococcus, Peptostreptococcus and some Bacteroides are mostly sensitive to this product, while Clostridium difficile is resistant to this product. The mechanism of action is to achieve bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

68401-82-1 21
Methionine Vitamin B1 for Injection
This product is a compound preparation: the main ingredients are methionine and vitamin B1, methionine: L-2-amino-4 (methylthio) butyric acid, vitamin B1: 4-methyl-3-[(2-methyl-4-amino-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)thiazolidine hydrochloride.
Name Description Content CAS NO. Registered Holders
DL-Methionine

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, enhances transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, promotes choline synthesis by supplying methyl groups, promotes liver fat metabolism, protects the liver and has detoxification effects.

More

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, enhances transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, promotes choline synthesis by supplying methyl groups, promotes liver fat metabolism, protects the liver and has detoxification effects.

59-51-8 10
Thiamine chloride

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and a-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism.

More

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and a-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism.

59-43-8 9
Methionine Vitamin B1 for Injection
This product is a compound preparation: the main ingredients are methionine and vitamin B1, methionine: L-2-amino-4 (methylthio) butyric acid, vitamin B1: 4-methyl-3-[(2-methyl-4-amino-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)thiazolidine hydrochloride.
Name Description Content CAS NO. Registered Holders
DL-Methionine

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, enhances transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, promotes choline synthesis by supplying methyl groups, promotes liver fat metabolism, protects the liver and detoxifies.

More

One of the eight essential amino acids for the human body, it combines with ATP to generate S-adenosine, promotes methylation of liver cell membrane phospholipids, reduces intrahepatic bile stasis, enhances transsulfurization, restores the physiological function of liver cells, promotes the disappearance of jaundice and recovery of liver function, promotes choline synthesis by supplying methyl groups, promotes liver fat metabolism, protects the liver and detoxifies.

59-51-8 10
Thiamine chloride

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and a-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism.

More

It combines with pyrophosphate in the body to form a cocarboxylase, participating in the oxidative decarboxylation reaction of pyruvate and a-ketoglutarate in sugar metabolism, and is necessary for sugar metabolism.

59-43-8 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.